98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169728 | PMC |
http://dx.doi.org/10.1016/j.gastha.2025.100685 | DOI Listing |
Gastro Hep Adv
April 2025
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Background: This study updates data on migraine prevalence in Spain, examining regional variations, healthcare resource utilization (HCRU), and patient-reported outcomes (PROs).
Methods: Cross sectional study using data from the 2022 National Health and Wellness Survey, an online survey of Spanish residents aged 18 or older. Respondents diagnosed with migraine by a physician and who reported at least one migraine in the past year were considered active migraine cases.
Dermatol Ther (Heidelb)
May 2025
Pfizer Inc, New York, NY, USA.
Introduction: Vitiligo may negatively impact quality of life (QOL). This study aimed to classify patients on the basis of the impact of vitiligo on emotional/psychological and social functioning and describe patient characteristics and patient-reported outcome (PRO) responses for each profile.
Methods: Physician and patient surveys from the Vitiligo Disease Specific Programme in France, Germany, Italy, Spain, and the USA were analyzed.
Gastro Hep Adv
January 2024
Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, New York.
Am Soc Clin Oncol Educ Book
June 2024
Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.